Vanguard Health Care ETF VHT

El Vanguard Health Care ETF busca seguir el rendimiento de la inversión del índice MSCI US Investable Market Health Care 25/50, un punto de referencia de acciones de gran, mediana y pequeña capitalización de Estados Unidos en el sector de la salud, según la clasificación del Global Industry Classification Standard (GICS). Este sector del GICS está compuesto por dos grupos principales de industrias. El primer grupo incluye empresas que fabrican equipos y suministros de atención médica o brindan servicios relacionados con la salud (como distribuidores de productos de atención médica, proveedores de servicios básicos de atención médica, y propietarios y operadores de instalaciones y organizaciones de atención médica). El segundo grupo incluye empresas principalmente involucradas en la investigación, desarrollo, producción y comercialización de productos farmacéuticos y biotecnológicos. The Vanguard Group, Inc., a través de su Grupo de Equidad Cuantitativa, actúa como asesor de inversiones del Fondo.

Con 3 acciones de VHT (USD 933,75) habrías recibido USD 13,86 en dividendos en los últimos 12 meses.

• The Motley Fool 10 sept

  Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPH

  Vanguard's VHT and State Street's XPH offer different approaches to healthcare investing. VHT provides broad sector exposure with lower costs (0.09% expense ratio) and higher dividend yield (1.5%), making it ideal for long-term investors. XPH focuses on pharmaceuticals with higher volatility but stronger 1-year returns (57.2% vs 29.3%), appealing to growth-oriented investors willing to accept greater risk.

  

• Zacks Investment Research 10 sept

  3 Healthcare Funds to Play Safe as Consumer Sentiment Hits a Low

  Rising oil prices due to U.S.-Iran tensions and weak consumer sentiment are creating market uncertainty. With inflation concerns and economic slowdown signals, three healthcare mutual funds are recommended as defensive investments: Vanguard Health Care Fund, Janus Henderson Global Life Sciences D, and Fidelity Select Health Care, all offering solid historical returns and low expense ratios.

  

• Zacks Investment Research 8 sept

  Should You Invest in the ALPS Medical Breakthroughs ETF (SBIO)?

  The ALPS Medical Breakthroughs ETF (SBIO) is a passively managed healthcare ETF that tracks small-cap and mid-cap pharmaceutical and biotechnology stocks in Phase II or Phase III FDA clinical trials. With a 0.5% expense ratio, $243.54 million in assets, and 107 holdings, it has delivered 32.1% year-to-date returns and 82.83% over 12 months. However, it carries high risk with a beta of 0.74 and 30.54% standard deviation. The fund received a Zacks ETF Rank of 3 (Hold), with alternatives like VHT and XLV offering lower expense ratios.

  

• The Motley Fool 1 sept

  Vanguard Health Care ETF vs Simplify Health Care ETF

  Vanguard Health Care ETF (VHT) offers broad healthcare exposure with a low 0.09% expense ratio and 1.5% dividend yield, while Simplify Health Care ETF (PINK) provides active management with higher 1-year returns (32.4% vs 29.3%) but charges 0.51% in fees. The author recommends Simplify despite Vanguard's better year-to-date performance, citing Simplify's superior longer-term returns and its pro bono model donating profits to breast cancer research.

  

• Zacks Investment Research 31 ago

  Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?

  RSPH, an equal-weight healthcare ETF launched in 2006, has gained 17.92% year-to-date and 29.15% over the past year as of August 31, 2026. With $826.52 million in assets and a 0.40% expense ratio, it offers diversified exposure to 63 healthcare holdings. However, cheaper alternatives like VHT (0.09% expense ratio) and XLV (0.08% expense ratio) may be more suitable for cost-conscious investors seeking lower-risk options.